Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis

Fig. 2

Production of Sm-Cathepsin B specific antibodies. Sm-cathepsin B specific total IgG a, IgG1 b and IgG2c c in immunized mice: Saline control, Montanide ISA 720 VG adjuvant control, and Sm-cathepsin B with Montanide ISA 720 VG. Serum from individual mice was analyzed by ELISA. Geometric means and 95 % confidence intervals are shown. Endpoint titers were determined for week 0, week 3, week 6, and week 9

Back to article page
\